Loading clinical trials...
Loading clinical trials...
CD123/CLL1 CAR-T Cell Therapy for Relapsed and Refractory Acute Myeloid Leukemia
Conditions
Interventions
CD123/CLL1 CAR-T Cells
Locations
1
China
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Start Date
August 10, 2018
Primary Completion Date
August 10, 2021
Completion Date
August 10, 2021
Last Updated
January 2, 2020
Lead Sponsor
Fujian Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions